PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29653519-10	2018	He was treated with oral prednisolone, resulting in the normalization of his serum VEGF level to 34.5 pg/mL 1 month after starting treatment.	Prednisolone	25-37	vascular endothelial growth factor A	Homo sapiens	83-87	
31978749-3	2020	The study assessed the effect of prednisolone treatment on the concentration of VEGF, pregnancy outcomes and variants of VEGF SNPs.	Prednisolone	33-45	vascular endothelial growth factor A	Homo sapiens	80-84	
31978749-3	2020	The study assessed the effect of prednisolone treatment on the concentration of VEGF, pregnancy outcomes and variants of VEGF SNPs.	Prednisolone	33-45	vascular endothelial growth factor A	Homo sapiens	121-125	
31978749-5	2020	The results inferred that the prednisolone made the concentration of VEGF significantly to normal levels along with other pregnancy-related and growth-related hormones.	Prednisolone	30-42	vascular endothelial growth factor A	Homo sapiens	69-73	
24739614-2	2014	He presented with a high level of serum vascular endothelial growth factor (VEGF) and RS3PE syndrome-like pitting edema in the extremities, which improved following treatment with low-dose prednisolone.	Prednisolone	189-201	vascular endothelial growth factor A	Homo sapiens	40-74	
24739614-2	2014	He presented with a high level of serum vascular endothelial growth factor (VEGF) and RS3PE syndrome-like pitting edema in the extremities, which improved following treatment with low-dose prednisolone.	Prednisolone	189-201	vascular endothelial growth factor A	Homo sapiens	76-80	
20889600-2	2010	And in subjects with severe disease activity, to compare the sensitivity of these measurements, acute-phase markers, and vascular endothelial growth factor to change in response to 2 weeks of oral prednisolone (7.5 mg daily).	Prednisolone	197-209	vascular endothelial growth factor A	Homo sapiens	121-155	
23010574-7	2012	Following up on this finding, we showed that the bidirectional effect of sodium taurocholate conjugation was due to its unique structure, that is, the sterane core hindering the ATIII-binding pentasaccharide unit of LMWH with its bulky and rigid structural characteristics while the terminal sulfate group interacts with VEGF to produce stronger binding.	Prednisolone	151-158	vascular endothelial growth factor A	Homo sapiens	321-325	
11481854-11	2001	After treatment with melphalan-prednisolone therapy, the neurological symptoms improved along with decrease of serum VEGF levels as well as the size of pulmonary plasmacytoma.	Prednisolone	31-43	vascular endothelial growth factor A	Homo sapiens	117-121	
15168155-3	2004	Vascular endothelial growth factor (VEGF) showed a high serum level, which decreased soon after starting oral prednisolone, in parallel with an improvement in the limb edema.	Prednisolone	110-122	vascular endothelial growth factor A	Homo sapiens	0-34	
15168155-3	2004	Vascular endothelial growth factor (VEGF) showed a high serum level, which decreased soon after starting oral prednisolone, in parallel with an improvement in the limb edema.	Prednisolone	110-122	vascular endothelial growth factor A	Homo sapiens	36-40	
14629962-14	2003	In contrast to controls, in prednisolone-treated animals VEGF mRNA and protein could not be detected in the hypertrophic zone of the growth plate.	Prednisolone	28-40	vascular endothelial growth factor A	Homo sapiens	57-61	
12431793-10	2002	Hydrocortisone (cortisol) and prednisolone also inhibited VEGF secretion, but they were less active than dexamethasone.	Prednisolone	30-42	vascular endothelial growth factor A	Homo sapiens	58-62	
11197800-3	2000	After prednisolone therapy, PH disappeared with a dramatic decrease in serum VEGF.	Prednisolone	6-18	vascular endothelial growth factor A	Homo sapiens	77-81	
9115750-10	1997	In the presence of the corticosteroids cortisone, hydrocortisone, dexamethasone, or prednisolone at nanomolar concentrations, this stimulus-dependent transcription of VEGF was abolished.	Prednisolone	84-96	vascular endothelial growth factor A	Homo sapiens	167-171	
11036826-6	2000	VEGF levels in blood samples obtained 4 or 5 months after the commencement of medication (combination of prednisolone 5 mg/day and disease modifying antirheumatic drugs: either bucillamine 100 mg/day or salazosulfapyridine 1,000 mg/day) were significantly decreased from 27.1 +/- 8.5 pg/ml in samples obtained before commencement of medication to 18.1 +/- 16.2 pg/ml.	Prednisolone	105-117	vascular endothelial growth factor A	Homo sapiens	0-4	
9506883-4	1998	The serum concentration of vascular endothelial growth factor, a cytokine that affects neovascularization, and vasopermeability, was elevated before the initiation of prednisolone treatment.	Prednisolone	167-179	vascular endothelial growth factor A	Homo sapiens	27-61